✦ LIBER ✦

Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children

✍ Scribed by Jeffrey Hyams; Wallace Crandall; Subra Kugathasan; Anne Griffiths; Allan Olson; Jewel Johanns; Grace Liu; Suzanne Travers; Robert Heuschkel; James Markowitz; Stanley Cohen; Harland Winter; Gigi Veereman–Wauters; George Ferry; Robert Baldassano

Book ID: 119759610
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 576 KB
Volume: 132
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2006.12.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction and Maintenance Adalimumab The

Induction and Maintenance Adalimumab Therapy for the Treatment of Moderate to Severe Crohn's Disease in Children

✍ Jeffrey S. Hyams; Anne M. Griffiths; James Markowitz; Robert Baldassano; William 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Safety and efficacy of maintenance infli

Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension

✍ Hyams, Jeffrey; Walters, Thomas D.; Crandall, Wallace; Kugathasan, Subra; Griffi 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 296 KB

P037 LONG-TERM EFFICACY AND SAFETY OF MA

P037 LONG-TERM EFFICACY AND SAFETY OF MAINTENANCE INFLIXIMAB THERAPY FOR THE TREATMENT OF MODERATE-TO-SEVERE PEDIATRIC CROHN'S DISEASE: RESULTS FROM THE REACH STUDY

✍ G. Veereman-Wauters; R. Baldassano; M. Blank; W. Crandall; A. Griffiths; R. Heus 📂 Article 📅 2009 🏛 Oxford University Press ⚖ 50 KB

Loss of Treatment Response to Infliximab

Loss of Treatment Response to Infliximab Maintenance Therapy in Crohn's Disease: A Payor Perspective

✍ Eric Qiong Wu; Parvez M. Mulani; Andrew Peng Yu; Jackson Tang; Paul F. Pollack 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

P302 The impact of induction and mainten

P302 The impact of induction and maintenance therapy with infliximab on mucosal healing and clinical remission in Polish pediatric patients with moderate to severe Crohn's disease

✍ J. Kierkus; E. Szymanska; M. Dadalski; A. Wegner; G. Oracz; M. Gorczewska; S. Sz 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 52 KB

Long-term outcome of maintenance inflixi

Long-term outcome of maintenance infliximab therapy in children with Crohn's disease

✍ Jeffrey S. Hyams; Trudy Lerer; Anne Griffiths; Marian Pfefferkorn; Subra Kugatha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i